(227 days)
No
The device description and performance studies focus on the mechanical and material properties of a standard syringe and needle, with no mention of AI or ML capabilities.
No
A hypodermic syringe is used for injecting or withdrawing fluids, which are common medical procedures, but the device itself does not provide therapy. The therapeutic effect comes from the substance being injected or withdrawn, not the syringe itself.
No
The document states that the device is used to inject or withdraw fluid from the body, which aligns with a therapeutic or procedural device, not a diagnostic one. Diagnostic devices are used to identify a condition, not to administer or remove substances.
No
The device description clearly outlines physical components like a barrel, plunger, nozzle, needle tube, needle hub, and needle cap, indicating it is a hardware device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is "to inject fluid into or withdraw fluid from the body." This describes a device used for direct interaction with the body for therapeutic or diagnostic purposes on the body, not for testing samples outside the body.
- Device Description: The description details a standard syringe and needle for injecting and withdrawing fluids. This aligns with a general medical device, not an IVD.
- Lack of IVD Characteristics: There is no mention of the device being used to examine specimens derived from the human body (like blood, urine, tissue, etc.) to provide information for diagnostic, monitoring, or compatibility purposes.
IVDs are specifically designed to perform tests on samples taken from the body. This device is designed to administer or remove substances directly from the body.
N/A
Intended Use / Indications for Use
SMB Hypodermic Syringe is used to inject fluid into or withdraw fluid from the body. This device is for single use only.
Product codes
FMF, FMF, FMI
Device Description
The SMB Luer lock disposable syringe is a standard Piston Syringe. It is a two-piece Syringe with male 6% luer lock connection. The Syringe is supplied with Hypodermic Needle having a female 6% luer hub. The Syringe and Needle are supplied sterilized by ETO gas. The device is single use device and non-pyrogenic. The device is available with 2ml Syringe and 23G Needle.
A detailed description of Syringe and Needle is as follows:
Syringe: The Syringe consists of hollow barrel with graduated scale and movable plunger. The barrel has a nozzle with a male luer lock connector that facilitates the connection with female luer lock hub of needle. The graduated scale on the barrel is indicated in the milliliters. The movable plunger is pulled to aspirate and pushed to inject the fluids into barrel.
Needle: The Needle consists of Needle tube, Needle cap. The Needle tube is attached to the Needle hub and the Needle hub is attached to the syringe by luer lock system. A cap is provided to protect Needle sharps protection as well as prevention of injury.
The materials used in manufacturing of Syringe & Needle are safe as demonstrated by the biocompatibility study performed for biological evaluation. Table 1 gives information about raw material.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-clinical tests were conducted to verify that the proposed devices met all design specifications. The test results demonstrated that the proposed device complies with the following standards:
ISO 7864:2016 - Sterile hypodermic needles for single use - Requirements and test methods
ISO 9626-2016 - Stainless steel needle tubing for the manufacture of medical devices - Requirements and test methods
ISO 594-1 - Conical fittings with a 6% (Luer) taper for syringes, needles and certain other medical equipment - Part 1: General requirements
ISO 594-2 - Conical fittings with a 6% (Luer) taper for syringes, needles and certain other medical equipment - Part 2: Lock fittings
ISO 7886-1:2017 - Sterile hypodermic syringes for single use - Part 1: Syringes for manual use
USP 32 NF27 - Sterility
USP - Bacterial Endotoxin test
USP - Particulate contamination
Biocompatibility based on ISO 10993-11:2021 (Acute Systemic toxicity), ISO 10993-5:2009 (Cytotoxicity), ISO 10993-10: 2021 (Skin sensitization study in guinea pigs, Intracutaneous reactivity test), USP-39 NF-34, Chapter 151 & ISO 10993-11 (Material mediated Pyrogenicity), ISO 10993-4 (Hemocompatibility Test), ISO 10993-4:2017 (Extract Method), ASTM F 756-17 (Direct Contact Method)
Packaging Test: ISO 11607-1:2019 2nd edition, ISO 11607-2:2019 2nd edition, ASTM D4169-16
Sterilization Test: ISO 11135:2014/AMD 1:2018 2nd edition (Ethylene oxide)
EO Residual Test: ISO 10993-7:2008
Bacterial Endotoxin Test: USP (Gel-Clot Method)
No clinical data is included in this premarket application submission.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 880.5860 Piston syringe.
(a)
Identification. A piston syringe is a device intended for medical purposes that consists of a calibrated hollow barrel and a movable plunger. At one end of the barrel there is a male connector (nozzle) for fitting the female connector (hub) of a hypodermic single lumen needle. The device is used to inject fluids into, or withdraw fluids from, the body.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA acronym with the full name of the agency on the right. The FDA part of the logo is in blue, with the acronym in a square and the full name written out to the right of the square.
January 12, 2024
SMB Corporation of India % Atonu Datta, CEO Alceon Medtech Consulting 1008, 10th Floor, "OCEAN", Sarabhai Compound Near Centre Square mall, Dr. V.S. Marg Vadodara, Gujarat 390023, India
Re: K231558
Trade/Device Name: SMB Luer lock disposable syringe Regulation Number: 21 CFR 880.5860 Regulation Name: Piston syringe Regulatory Class: Class II Product Code: FMF, FMF, FMI Dated: December 5, 2023 Received: December 11, 2023
Dear Atonu Datta:
We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).
1
Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30, Design controls; 21 CFR 820.90, Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely, Shruti N. Mistry -S
Shruti Mistry Assistant Director DHT3C: Division of Drug Delivery and General Hospital Devices, and Human Factors OHT3: Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
2
Indications for Use
510(k) Number (if known) K231558
Device Name SMB Luer lock disposable syringe
Indications for Use (Describe)
SMB Hypodermic Syringe is used to inject fluid into or withdraw fluid from the body. This device is for single use only.
| Type of Use (Select one or both, as applicable) |
|---|
| ------------------------------------------------- |
| Residential (Part 9, OBC, M-1 Division) | Care, Custodial (Part 3, OBC, M-2 Division) |
|---|---|
| ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |
X Prescription Use (Part 21 CFR 801 Subpart D)
| | Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
1. Submission Sponsor
Mr. Anupam Rai Chief QA Phone: +91260 2560209/+91 9930726998 Email id: qualityassurance@smbcorpn.com
SMB Corporation of India,
Plot No. 156 GIDC Umbergaon, Dist. Valsad 396170 Mfg. License No.: MFG/MD/2021/000092
2. Primary Correspondent
Mr. Atonu Dutta CEO Phone: (+91) 9925023428 Email: regulatory@alceonconsulting.com
Alceon Medtech Consulting
1008, 10th Floor, "OCEAN", Sarabhai Compound, Near Centre Square mall, Dr. V.S. Marg, Vadodara, Gujarat-390023, India. Phone: (+91) 9925023428
3. Date of preparing the summary
01/05/2024
4. Device Details
| Device name (Generic): | Hypodermic Syringe with Needle |
|---|---|
| Device name (Trade Name): | SMB Luer lock disposable syringe |
| Classification Regulation: | 21 CFR 880.5860, 21 CFR 880.5570 |
| Device Class: | Class II |
| Product Code: | FMF, FMI |
| Panel: | General hospital |
4
5. Predicate Device
| Subject Device
Manufacturer | Subject Device | Primary Predicate
Device 510K | Secondary
Predicate Device
510K |
|--------------------------------|----------------------------------------------------------|----------------------------------|---------------------------------------|
| SMB
Corporation of
India | Sterile, Single use
Hypodermic Syringe With
needle | K202432 | K102584
(For Needle) |
6. Device Description
The SMB Luer lock disposable syringe is a standard Piston Syringe. It is a two-piece Syringe with male 6% luer lock connection. The Syringe is supplied with Hypodermic Needle having a female 6% luer hub. The Syringe and Needle are supplied sterilized by ETO gas. The device is single use device and non-pyrogenic. The device is available with 2ml Syringe and 23G Needle.
A detailed description of Syringe and Needle is as follows:
Syringe: The Syringe consists of hollow barrel with graduated scale and movable plunger. The barrel has a nozzle with a male luer lock connector that facilitates the connection with female luer lock hub of needle. The graduated scale on the barrel is indicated in the milliliters. The movable plunger is pulled to aspirate and pushed to inject the fluids into barrel.
Needle: The Needle consists of Needle tube, Needle cap. The Needle tube is attached to the Needle hub and the Needle hub is attached to the syringe by luer lock system. A cap is provided to protect Needle sharps protection as well as prevention of injury.
The materials used in manufacturing of Syringe & Needle are safe as demonstrated by the biocompatibility study performed for biological evaluation. Table 1 gives information about raw material.
| Components | Material | Grade | CAS No. | Type of
Body
Contact |
|------------|---------------|----------|-----------|-----------------------------------------|
| Barrel | Polypropylene | RF830MO | 9010-79-1 | In direct
contact with
blood path |
| Plunger | HDPE | EHM 6007 | 9002-88-4 | In direct
contact with
blood path |
Table: 1 Raw Material
5
| Components | Material | Grade | CAS No. | Type of
Body
Contact |
|-----------------|-------------------------------------|----------|-----------|-----------------------------------------|
| Needle tube | Stainless steel | SS304 | N/A | Direct
contact with
blood path |
| Needle hub | Polypropylene
(Deep Blue colour) | RF830MO | 9010-79-1 | In direct
contact with
blood path |
| Needle
cover | HDPE | EHM 6007 | 9002-88-4 | No contact |
Indication for use:
SMB Hypodermic Syringe is used to inject fluid into or withdraw fluid from the body. This device is for single use only.
7. Comparison to a predicate device
| Description | Subject Device
(Applied) | Primary Predicate Device
(K202432) | Comparison |
|------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------|
| Trade/Device
Name | SMB Luer lock disposable
syringe | MiniLoad Syringe | - |
| Manufacturer | SMB Corporation of India | OcuJect, LLC | - |
| 510 (K) | Applied | K202432 | - |
| Class | Class II | Class II | Same |
| Regulatory
number | 21 CFR Part 880.5860 | 21 CFR Part 880.5860 | Same |
| Product code | FMF | FMF | Same |
| Syringe type | Piston Syringe | Piston Syringe | Same |
| Indication for
use | SMB Hypodermic Syringe is
device that is used to inject
fluid into or withdraw fluid
from the body. This device is
used for single use only. | The MiniLoad Syringe is
used to facilitate
injections into or
withdraw fluids from
body. | Same |
| Configuration | Barrel | Barrel | Same |
| | Plunger | Plunger | |
| Materials | | | |
| Description | Subject Device
(Applied) | Primary Predicate Device
(K202432) | Comparison |
| Barrel | Polypropylene | Polypropylene | Same |
| Plunger | Polyethylene | Polyethylene | Different 1 |
| Lubricant | Silicone oil | Oleamide | Different 1 |
| Principle of
operation | Piston Syringe | Piston Syringe | Same |
| Technical specification | | | |
| Barrel Length | $62 \pm 5mm$ | $\sim 85 mm$ | Different 2 |
| Barrel Diameter | $10.30 \pm 0.10mm$ | $\sim 6.4 mm$ | Different 3 |
| Barrel Size
(Volume) | 2 ml | 1 ml | Different 4 |
| Plunger Length | $64 \pm 5mm$ | 93.4 | Different 5 |
| Nozzle type | Luer-lock | Slip Tip | Different 6 |
| Graduation | Printed, ISO 7886-1
compliant | Printed, ISO 7886-1
compliant | Same |
| Barrel
transparency | Transparent (Fluid & scale
marking clearly visible) | Transparent | Same |
| Reuse durability | Single use only | Single use only | Same |
| Sterilization
Method | EO | EO | Same |
| SAL | $10^6$ | $10^6$ | Same |
| Biocompatibility | 1. Cytotoxicity
2. Sensitization
3. Irritation or
Intracutaneous
reactivity
4. Acute systemic
toxicity
5. Material mediated
pyrogenicity
6. Hemocompatibility | 1. Cytotoxicity
2. Sensitization
3. Irritation or
Intracutaneous
reactivity
4. Acute systemic
toxicity
5. Material mediated
pyrogenicity
6. Hemocompatibility | Same |
| Particulate
Contamination | Met the USP | Met the USP | Same |
| Label/Labelling | Conform with 21 CFR 801 | Conform with 21 CFR 801 | Same |
| Shelf Life | 5 years | 5 Years | Same |
| Description | Subject Device
(Applied) | Secondary Predicate
Device
(K102584) | Comparison |
| Class | Class II | Class II | Same |
| Regulatory number | 21 CFR Part
880.5570 | 21 CFR Part 880.5570 | Same |
| Product code | FMI | FMI | Same |
| Configuration | Needle Hub
Needle
Needle Cover | Needle Hub
Needle
Needle Cover | Same |
| Materials | | | |
| Needle Hub | Polypropylene | Polypropylene | |
| Needle | S.S 304 | S.S 304 | Different 7 |
| Needle Cover | HDPE | Polypropylene | |
| Technical specification | | | |
| Needle gauge | 23 G | 16 G to 30 G | Same- (Predicate
device have some
additional gauge
sizes) |
| Nozzle type | Luer-lock | Luer-lock/ Luer-Slip | Same- (Predicate
device have
additional nozzle
type) |
| Needle cover color | Transparent | Transparent | Same |
| Hub/needle bond
strength | Complies as per ISO
7864:2016 | Complies as per ISO
7864:2016 | Same |
1. Comparison of Syringe to Predicate Device
6
7
2. Comparison of Needle to Predicate Device
Summary of Substantial Equivalence:
Different 1, 7:
The subject and predicate devices contain a similar generic class of materials. However, the exact material grade of the predicate device is not publicly available. There may also be differences in manufacturing and processing aids that may result in a different finished material. Therefore, testing per ISO 10993 and the FDA Guidance "Use of International Standard ISO 10993-1, "Biological evaluation of medical devices - Part 1: Evaluation and testing
SMB Corporation of India.
8
within a risk management process" was performed to assess the biological impact of the finished material.
The results of biocompatibility studies were found satisfactory, and we conclude that the materials do not impact the safety and effectiveness of the subject device compared to the predicate device. Hence, the difference can be considered acceptable.
Different 2, 3, 4, 5:
The intended use of different sizes is the same as the predicate device. The raw material used for the subject device is similar to the predicate device. However, there may be differences in manufacturing and processing that results in a different finished material. Additionally, the device is tested in accordance with the ISO 7886-1:2017, ISO 80369-7:2016, ISO 7864:2016 standards and the results were found satisfactory. Considering these factors, the dimensional difference of barrel & needle does not impact the safety and effectiveness of the subject device when compared to the predicate device. Hence, the difference can be considered acceptable.
Different 6:
The predicate Hypodermic Needle is attached to the Hypodermic Syringe by means of lock or push fit (Slip) style. The subject device is attached by means of Luer-lock system. To address this difference, the subject device is tested in accordance with the ISO 7886-1:2017, ISO 80369-7:2016, ISO 7864:2016 standards and the results were found satisfactory. Considering the above difference, it is concluded that Luer-lock system will not result in liquid leakage and prevents accidental removal of needle. Hence, this difference can be considered acceptable.
For the needle cover, different materials were used for the subject device and predicate devices. Testing per ISO 10993 and the FDA Guidance "Use of International Standard ISO 10993-1, "Biological evaluation of medical devices - Part 1: Evaluation and testing within a rick management process" was performed in order to assess the differences in finished material.
The results of biocompatibility were found satisfactory and the material difference does not impact the safety and effectiveness of the subject device when compared to the predicate device. Hence, the difference can be considered acceptable.
8. Summary of non-clinical performance data
Non-clinical tests were conducted to verify that the proposed devices met all design specifications. The test results demonstrated that the proposed device complies with the following standards:
9
| STANDARDS | TEST PARAMETERS |
|---|---|
| ISO 7864:2016 | Sterile hypodermic needles for single use - Requirements and test |
| methods | |
| ISO 9626-2016 | Stainless steel needle tubing for the manufacture of medical devices |
- Requirements and test methods |
| ISO 594-1 | Conical fittings with a 6% (Luer) taper for syringes, needles and
certain other medical equipment - Part 1: General requirements |
| ISO 594-2 | Conical fittings with a 6% (Luer) taper for syringes, needles and
certain other medical equipment - Part 2: Lock fittings |
| ISO 7886-1:2017 | Sterile hypodermic syringes for single use - Part 1: Syringes for manual
use |
| USP 32 NF27 | Sterility |
| USP | Bacterial Endotoxin test |
| USP | Particulate contamination |
| Biocompatibility | |
| ISO 10993-11:2021 | Acute Systemic toxicity |
| ISO 10993-5:2009 | Cytotoxicity |
| ISO 10993-10: 2021 | Skin sensitization study in guinea pigs |
| ISO 10993-10: 2021 | Intracutaneous reactivity test |
| USP-39
NF-34,
Chapter 151 & ISO
10993-11 | Material mediated Pyrogenicity |
| ISO 10993-4 | Hemocompatibility Test |
| ISO 10993-4:2017 | Extract Method |
| ASTM F 756-17 | Direct Contact Method |
| Packaging Test: | |
| ISO 11607-1:2019
2nd edition | Packaging for terminally sterilized medical devices - Part 1:
Requirements for materials, sterile barrier systems, and packaging
systems |
| ISO 11607-2:2019
2nd edition | Packaging for terminally sterilized medical devices - Part 2:
Validation requirements for forming, sealing, and assembly
processes |
| ASTM D4169-16 | Standard Practice for Performance Testing of Shipping Containers
and Systems |
| Sterilization Test: | |
| STANDARDS | TEST PARAMETERS |
| ISO
11135:2014/AMD
1:2018 2nd edition | Sterilization of health care products - Ethylene oxide - Requirements
for development, validation, and routine control of a sterilization
process for medical devices. |
| EO Residual Test: | |
| ISO 10993-7:2008 | Biological evaluation of medical devices - Part 7: Ethylene oxide
sterilization residuals, and it meets the requirements of the
standard. |
| Bacterial Endotoxin Test: | |
| USP | The Bacterial endotoxin testing of subject devices was performed by
the "Gel-Clot Method" and meets the requirement of USP . |
10
9. Summary of clinical performance data
No clinical data is included in this premarket application submission.
10. Conclusion
The differences between the predicate and the subject device do not raise any new or different questions of safety or effectiveness. Based on the comparison and analysis above, the proposed device is determined to be Substantially Equivalent (SE) to the predicate devices.